Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :i

    

• Editorials

  • ·How do I/We forecast tomorrow’s transfusion? A series of experts’ proposals for changes in transfusion medicine

    Page :1-2

    Olivier Garraud, France Pirenne, On behalf of the Editorial Board of the Journal and the French Society for Blood Transfusion

    
  • ·Platelet transfusion in adults: more to know?

    Page :3-4

    France Pirenne, Thierry Facon

    Plan Plan

• Clinical studies

  • ·A case of severe hemolytic disease of newborn due to alloimmunization in primigravida

    Page :5-7

    Prashant Pandey, Supriya Kumari, Saikat Mandal, Ashu Sawhney, Reenu Jain

    Résumé Résumé Plan Plan  
  • ·A rare case of clinically significant naturally occurring anti-C^w reported in a healthy male donor

    Page :8-10

    Prashant Pandey, Supriya Kumari, Divya Setya, Mukesh Kumar Singh

    Résumé Résumé Plan Plan  
  • ·Don’t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia

    Page :11-15

    İsmail Ucar, Mahmut Bakir Koyuncu, Ali Alper Solmaz, Adil Can Ugurludogan, Seda Mercan, Mehmet Kucuk, Tufan Unal, Semir Mazman, Erden Atilla

    Résumé Résumé Plan Plan  
  • ·Therapeutic plasma exchange as a treatment modality for steroid refractory acute disseminated encephalomyelitis – A case report

    Page :16-18

    Kaur Pandeep, Kumar Rakesh, Singh Mohitpreet, Singh Prabhjeet

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence

    Page :19

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

    
  • ·Mothers still die due to blood shortages in developing countries: A call for ethical consideration

    Page :19-20

    Grant Murewanhema, Mathias Dzobo, Tafadzwa Dzinamarira

    
  • ·Averting transfusion related catastrophe during blood administration: Backing transfusion bioethics

    Page :20-21

    Manish Raturi, Akanksha Raj, Yashaswi Dhiman, Adityaveer Sahrawat

    Plan Plan
  • ·Seroprevalence surveys in blood donors population and complexity of immunization patterns

    Page :21

    Pierre Gallian, Nadége Brisbarre, Christine Isnard, Pascal Morel, Xavier de Lamballerie

    
  • ·Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence

    Page :22

    Pathum Sookaromdee, Viroj Wiwanitkit

    
  • ·Nomenclature of allergy: Past and present

    Page :22-24

    Han Zhang, Bikun Wang, Yanfen Zhang, Zhongcheng Liu

    Plan Plan  
  • ·Blister formation at post donation phlebotomy site after topical application of combination of Benzyl Nicotinate and Heparin: An unpleasant post donation experience

    Page :24-25

    Parmatma Prasad Tripathi, Vijay Kumawat, Nishanth Budanuru Shankara

     
  • ·Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021

    Page :25-26

    Pierre Gallian, Ahmed Slimani, Lucile Malard, Pascal Morel, Xavier de Lamballerie

     

• Research perspectives

  • ·How do I/we forecast tomorrow’s transfusion? A focus on recipients’ profiles

    Page :27-30

    Suma Choorapoikayil, Lotta Hof, Oliver Old, Andrea Steinbicker, Patrick Meybohm, Kai Zacharowski

    Résumé Résumé Plan Plan  
  • ·How do we forecast tomorrow’s transfusion? — Next generation transfusion practices to improve recipient safety

    Page :31-34

    Neil Blumberg, Joanna Mary Heal

    Résumé Résumé Plan Plan
  • ·How do we forecast tomorrow’s transfusion: Infectious safety?

    Page :35-38

    Roger Y. Dodd, Susan L. Stramer

    Résumé Résumé Plan Plan
  • ·How do we forecast tomorrow’s transfusion? Prehospital transfusion

    Page :39-42

    Mark H. Yazer, Donald H. Jenkins, Jason L. Sperry, Philip C. Spinella

    Plan Plan
  • ·How do I/we forecast tomorrows’ transfusion: Blood components

    Page :43-46

    Nicolas Pereyra, Dana V. Devine

    Résumé Résumé Plan Plan
  • ·How do we forecast tomorrow’s transfusion? Applying social science approaches to meet tomorrow’s transfusion needs: Blood donors and donation

    Page :47-51

    Jennie Haw, Kelly Holloway, Mindy Goldman

    Plan Plan
  • ·How do we forecast tomorrow’s transfusion: The future of hematopoietic stem cell donation

    Page :52-55

    Lina Hamad, Chloe Anthias, Laura Machin

    Plan Plan  

• Original articles

  • ·Review of blood donor deferral with emphasis on donor and patient safety

    Page :56-62

    Divjot Singh Lamba, Suchet Sachdev, Rekha Hans, Hari Krishan Dhawan, Ratti Ram Sharma, Neelam Marwaha

    Résumé Résumé Plan Plan   
  • ·Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol

    Page :63-68

    Siddharth Bhatia, Paramjit Kaur, Gagandeep Kaur, Anita Tahlan, Varinder Saini, Ravneet Bedi, Kshitija Mittal, Tanvi Sood

    Résumé Résumé Plan Plan  
  • ·No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis

    Page :69-74

    Arisha Saleem, Eisha Waqar, Syed Hasan Shuja, Unaiza Naeem, Abdul Moeed, Heena Rais, Jawad Ahmed

    Résumé Résumé Plan Plan   
  • ·Restrictive blood transfusion and 1-year mortality in patients undergoing open abdominal surgery: A retrospective propensity score-matched cohort study

    Page :75-81

    Mutsuhito Kikura, Masahiro Uraoka, Junko Nishino

    Résumé Résumé Plan Plan
  • ·Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusion

    Page :82-86

    Neslihan Meric, Ayhan Parmaksız, Zafer Gulbas

    Résumé Résumé Plan Plan  
  • ·Synergistic activity of vitamin-C and vitamin-E to ameliorate the efficacy of stored erythrocytes

    Page :87-95

    Masannagari Pallavi, Vani Rajashekaraiah

    Résumé Résumé Plan Plan  
  • ·Significance of mandating a dedicated hemovigilance nurse and objectification of ‘imputability’ levels. Experience from a hospital-based blood centre in India

    Page :96-102

    Yashaswi Dhiman, Manish Raturi, Mansi Kala, Anuradha Kusum

    Résumé Résumé Plan Plan  
  • ·Validating a blood donation awareness tool created using general practitioner and patient acceptability and preferences

    Page :103-110

    A. Jouannin, E. Robin, S. Bouvet, A. Chevance, P. Le Douaron, M. Esvan, B. Danic, M.-F. Mamzer, J.-B. Thibert

    Résumé Résumé Plan Plan   
  • ·Human neutrophil antigen‐1, -3, -4, and -5 allele and genotype frequencies in the Croatian blood donor population and their clinical significance

    Page :111-115

    R. Stimac, M. Tomicic, J. Bingulac-Popovic, R. Kundid, I. Babic, A. Hecimovic, T. Vuk, I. Jukic

    Résumé Résumé Plan Plan
  • ·Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort

    Page :116-122

    Meryem Cetin, Sirin Cetin, Ayse Ulgen, Wentian Li

    Résumé Résumé Plan Plan   
  • ·Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic

    Page :123-129

    Fahimeh Ranjbar Kermani, Ali Arabkhazaeli, Peyman Eshghi, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad, Amir Teimourpour, Mahmoud Reza Pourkarim

    Résumé Résumé Plan Plan  
  • ·Association of blood donor’s biological characteristics on outcomes of cardiac surgery patients receiving red blood cells transfusion

    Page :130-136

    Vidushi Gupta, Gopal K. Patidar, Milind Hote, Radheshyam Mehar, Yashaswi Dhiman, Anjali Hazarika

    Résumé Résumé Plan Plan  
  • ·Real-world data from India on clinical practices in the management of autoimmune haemolytic anaemia: A survey-based cross-sectional assessment

    Page :137-142

    Sudipta Sekhar Das, Soumya Das, Shamee Shastry, Veena Shenoy, Saikat Mandal, Suvro Sankha Datta

    Résumé Résumé Plan Plan   

• Short communication

  • ·Merkel cell polyomavirus (MCPyV) DNA prevalence in Brazilian blood donors

    Prévalence De L'adn du polyomavirus des cellules De Merkel (MCPyV) Chez Les Donneurs De Sang Brésiliens

    Page :143-146

    Victoria Simionatto Zucherato, Perícles Natan Mendes da Costa, Marta Giovanetti, Luciana Maria Fontanari Krause, Daiani Cristina Cilião Alves, Renata Maria Alencar Moreira, Barbara Maciel Sidou Pimentel, Rodrigo Haddad, Hellen Tayaná Bitencourt, Massimo Ciccozzi, Luiz Carlos Júnior Alcantara, Simone Kashima, Dimas Tadeu Covas, Svetoslav Nanev Slavov

    Résumé Résumé Plan Plan  

• Review articles

  • ·Platelet transfusion in adults: An update

    Page :147-165

    O. Garraud, H. Hamzeh-Cognasse, E. Chalayer, A.C. Duchez, B. Tardy, P. Oriol, A. Haddad, D. Guyotat, F. Cognasse

    Résumé Résumé Plan Plan
  • ·Thirty years of hemovigilance – Achievements and future perspectives

    Page :166-172

    Tomislav Vuk, Constantina Politis, Stefan Laspina, Miquel Lozano, Antoine Haddad, Vincenzo de Angelis, Olivier Garraud, European and Mediterranean Initiative in Transfusion medicine (EMITm) group

    Résumé Résumé Plan Plan

• Acknowledging our reviewers 2022

  • ·Acknowledging our reviewers

    Page :173